Non-small cell lung cancer with iris metastasis controlled with osimertinib and monthly intravitreal bevacizumab

PURPOSE: Iris metastases from lung cancer occur rarely. Current treatment options such as surgical iridectomy or radiotherapy are invasive and can potentially lead to negative side effects. Other less invasive alternatives include chemotherapy and intracameral bevacizumab. OBSERVATIONS: An 81 year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Margaret, Frank, James H., Shields, Carol L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790597/
https://www.ncbi.nlm.nih.gov/pubmed/35112017
http://dx.doi.org/10.1016/j.ajoc.2022.101269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790597/
https://www.ncbi.nlm.nih.gov/pubmed/35112017
http://dx.doi.org/10.1016/j.ajoc.2022.101269

Ejemplares similares